354 related articles for article (PubMed ID: 10424518)
1. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases.
Yoshino I; Nakanishi R; Osaki T; Takenoyama M; Taga S; Hanagiri T; Yasumoto K
Chest; 1999 Jul; 116(1):144-9. PubMed ID: 10424518
[TBL] [Abstract][Full Text] [Related]
2. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
[TBL] [Abstract][Full Text] [Related]
3. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer.
Osaki T; Nagashima A; Yoshimatsu T; Tashima Y; Yasumoto K
Lung Cancer; 2004 Feb; 43(2):151-7. PubMed ID: 14739035
[TBL] [Abstract][Full Text] [Related]
4. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
5. Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival?
Luzzi L; Voltolini L; Campione A; Paladini P; Ghiribelli C; Di Bisceglie M; Gotti G
J Cardiovasc Surg (Torino); 2003 Feb; 44(1):119-23. PubMed ID: 12627083
[TBL] [Abstract][Full Text] [Related]
6. Prognostic variability among nonsmall cell lung cancer patients with pathologic N1 lymph node involvement. Epidemiological figures with strong clinical implications.
Caldarella A; Crocetti E; Comin CE; Janni A; Pegna AL; Paci E
Cancer; 2006 Aug; 107(4):793-8. PubMed ID: 17024758
[TBL] [Abstract][Full Text] [Related]
7. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes.
Yano T; Yokoyama H; Inoue T; Asoh H; Tayama K; Ichinose Y
J Thorac Cardiovasc Surg; 1994 Jun; 107(6):1398-402. PubMed ID: 8196379
[TBL] [Abstract][Full Text] [Related]
8. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
Park S; Cho S; Yum SW; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
[TBL] [Abstract][Full Text] [Related]
11. Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer.
Haney JC; Hanna JM; Berry MF; Harpole DH; D'Amico TA; Tong BC; Onaitis MW
J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1164-8. PubMed ID: 24507984
[TBL] [Abstract][Full Text] [Related]
12. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy.
Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y
Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung.
Matsuoka K; Sumitomo S; Misaki N
J Thorac Oncol; 2007 Dec; 2(12):1098-102. PubMed ID: 18090581
[TBL] [Abstract][Full Text] [Related]
15. Impact of main bronchial lymph node involvement in pathological T1-2N1M0 non-small-cell lung cancer: multi-institutional survey by the Japan National Hospital Study Group for Lung Cancer.
Maeda H; Fukai S; Matsumura A; Kawashima O; Watanabe T; Yamanda T; Okabayashi K; Fujita Y; Tamura A; Kawahara M
Gen Thorac Cardiovasc Surg; 2009 Nov; 57(11):599-604. PubMed ID: 19908114
[TBL] [Abstract][Full Text] [Related]
16. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
Wang S; Zhou W; Zhang H; Zhao M; Chen X
Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
[TBL] [Abstract][Full Text] [Related]
17. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
[TBL] [Abstract][Full Text] [Related]
18. Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
Razi SS; Nguyen D; Villamizar N
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2469-2483.e4. PubMed ID: 31928821
[TBL] [Abstract][Full Text] [Related]
19. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
20. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
